BACKGROUND: This study was conducted to establish an objective approach to evaluate symptoms and sweat production in patients with primary palmoplantar hyperhidrosis (PPH) and assess their response to bilateral thoracoscopic sympathectomy (BTS). METHODS: We conducted two institutional review board-approved studies. We performed a one-time evaluation of healthy volunteers (controls) with three questionnaires (Hyperhidrosis Disease Severity Scale, Dermatology Life Quality Index, and Short Form-36) and measurement of transepidermal water loss (TEWL; g/m(2)/h). We evaluated PPH patients with these same tools before and 1 month after BTS and compared them with controls. RESULTS: We evaluated 35 controls (mean age, 23.0 +/- 3.3 years) and 45 PPH patients (mean age, 26.5 +/- 12.3 years); 18 PPH patients underwent BTS and the 1-month postoperative evaluation. Hyperhidrosis Disease Severity Scale and Dermatology Life Quality Index scores were higher in PPH patients than in controls (p < 0.0001), but normalized after BTS. Short Form-36 scale scores were lower in PPH patients than in controls (p < 0.05), but improved significantly after BTS. Compared with controls, preoperative TEWL values were significantly higher in PPH patients (palmar: 142.7 +/- 43.6 PPH vs 115.8 +/- 48.7 controls, p = 0.011; plantar: 87.5 +/- 28.8 PPH vs 57.7 +/- 24.7 controls, p < 0.0001). After BTS, palmar TEWL values were significantly lower (49.1 +/- 29.8, p < 0.0001). Plantar TEWL did not change significantly (77.6 +/- 46.6, p = 0.52). CONCLUSIONS: PPH patients should be objectively evaluated with standardized quality of life measures and TEWL measurements before and after treatment. We believe that this objective practical approach provides a benchmark for clinical practice and research.
BACKGROUND: This study was conducted to establish an objective approach to evaluate symptoms and sweat production in patients with primary palmoplantar hyperhidrosis (PPH) and assess their response to bilateral thoracoscopic sympathectomy (BTS). METHODS: We conducted two institutional review board-approved studies. We performed a one-time evaluation of healthy volunteers (controls) with three questionnaires (Hyperhidrosis Disease Severity Scale, Dermatology Life Quality Index, and Short Form-36) and measurement of transepidermal water loss (TEWL; g/m(2)/h). We evaluated PPHpatients with these same tools before and 1 month after BTS and compared them with controls. RESULTS: We evaluated 35 controls (mean age, 23.0 +/- 3.3 years) and 45 PPHpatients (mean age, 26.5 +/- 12.3 years); 18 PPHpatients underwent BTS and the 1-month postoperative evaluation. Hyperhidrosis Disease Severity Scale and Dermatology Life Quality Index scores were higher in PPHpatients than in controls (p < 0.0001), but normalized after BTS. Short Form-36 scale scores were lower in PPHpatients than in controls (p < 0.05), but improved significantly after BTS. Compared with controls, preoperative TEWL values were significantly higher in PPHpatients (palmar: 142.7 +/- 43.6 PPH vs 115.8 +/- 48.7 controls, p = 0.011; plantar: 87.5 +/- 28.8 PPH vs 57.7 +/- 24.7 controls, p < 0.0001). After BTS, palmar TEWL values were significantly lower (49.1 +/- 29.8, p < 0.0001). Plantar TEWL did not change significantly (77.6 +/- 46.6, p = 0.52). CONCLUSIONS:PPHpatients should be objectively evaluated with standardized quality of life measures and TEWL measurements before and after treatment. We believe that this objective practical approach provides a benchmark for clinical practice and research.
Authors: John L D Atkinson; Nicolee C Fode-Thomas; Robert D Fealey; John H Eisenach; Stephan J Goerss Journal: Mayo Clin Proc Date: 2011-08 Impact factor: 7.616
Authors: Ole B Pedersen; Gregor B E Jemec; Mattias A S Henning; Kristina S Ibler; Isabella Loft; Sisse R Ostrowski; Christian Erikstrup; Kaspar R Nielsen; Mie T Bruun; Henrik Ullum; Maria Didriksen; Khoa M Dinh Journal: Qual Life Res Date: 2022-02-22 Impact factor: 4.147
Authors: L M Nelson; D DiBenedetti; D M Pariser; D A Glaser; A A Hebert; H Hofland; J Drew; D Ingolia; K K Gillard; S Fehnel Journal: J Patient Rep Outcomes Date: 2019-09-05
Authors: Michaela Gabes; Helge Knüttel; Gesina Kann; Christina Tischer; Christian J Apfelbacher Journal: Qual Life Res Date: 2021-07-30 Impact factor: 4.147
Authors: Nelson Wolosker; Augusto Ishy; Guilherme Yazbek; Jose Ribas Milanez de Campos; Paulo Kauffman; Pedro Puech-Leão; Fabio Biscegli Jatene Journal: Clinics (Sao Paulo) Date: 2013 Impact factor: 2.365